Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 31)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
9-Feb-10New Constructs, LLCN/AALKS: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10  View Abstract
9-Feb-10EconomicInvestorN/A"The Economy Matters" Report for ALKS: the economy's impact on ALKS's price and risk, featuring the powerful EconomicInvestor Star Rating6$15  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199  View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)100$169  View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (United States)98$169  View Abstract
7-Feb-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ALKERMES INC5$25  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: ALKERMES -- ALKS1$4  View Abstract
5-Feb-10Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ALKERMES INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: ALKS , HITK , LGND , PANC , PPCO , UTHR -- DRUGS3$4  View Abstract
Next 20

Independent Reports (Showing 1 to 10 of 31)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
9-Feb-10New Constructs, LLCN/AALKS: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10View Abstract
9-Feb-10EconomicInvestorN/A"The Economy Matters" Report for ALKS: the economy's impact on ALKS's price and risk, featuring the powerful EconomicInvestor Star Rating6$15View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)100$169View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (United States)98$169View Abstract
7-Feb-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ALKERMES INC5$25View Abstract
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: ALKERMES -- ALKS1$4View Abstract
5-Feb-10Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ALKERMES INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: ALKS , HITK , LGND , PANC , PPCO , UTHR -- DRUGS3$4View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.